Expand DBVT Menu
DBVT MENU

DBVT Latest Press Releases

-- July 30, 2026 --

DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq Globe Newswire 5:40 PM

-- July 17, 2026 --

DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales Globe Newswire 5:00 PM

-- July 16, 2026 --

DBV Technologies Announces the Filing of its 2026 Half-Year Report ? Conditions for Accessing or Consulting the Report Globe Newswire 4:10 PM
DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update Globe Newswire 4:01 PM

-- July 14, 2026 --

DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026 Globe Newswire 4:30 PM

-- July 6, 2026 --

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF Globe Newswire 4:30 PM

-- June 29, 2026 --

DBV Technologies Provides BLA Submission Update for the VIASKIN Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing Globe Newswire 4:00 PM

-- June 23, 2026 --

DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index Globe Newswire 4:30 PM

-- June 9, 2026 --

DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference Globe Newswire 7:00 AM

-- June 8, 2026 --

DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 Globe Newswire 4:35 PM

-- June 5, 2026 --

DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference Globe Newswire 4:30 PM

-- June 3, 2026 --

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026 Globe Newswire 4:31 PM
DBV Technologies Announces the Results of its 2026 Combined General Meeting Globe Newswire 4:30 PM

-- June 2, 2026 --

DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy Globe Newswire 7:40 PM

-- May 13, 2026 --

Combined General Meeting of June 3, 2026 Globe Newswire 4:30 PM

-- May 12, 2026 --

DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq Globe Newswire 4:30 PM

-- April 30, 2026 --

DBV Technologies Reports First Quarter 2026 Financial Results Globe Newswire 4:30 PM

-- April 2, 2026 --

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 Globe Newswire 4:30 PM

-- March 26, 2026 --

DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document Globe Newswire 5:19 PM
DBV Technologies Reports Full Year 2025 Financial Results and Business Update Globe Newswire 5:06 PM

-- March 24, 2026 --

DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review Globe Newswire 4:30 PM
Market Data Delayed 15 Minutes